nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—CYP3A4—prostate cancer	0.14	1	CbGaD
Telaprevir—ORM1—Abiraterone—prostate cancer	0.11	0.211	CbGbCtD
Telaprevir—ALB—Abiraterone—prostate cancer	0.0462	0.0886	CbGbCtD
Telaprevir—ALB—Estrone—prostate cancer	0.0334	0.064	CbGbCtD
Telaprevir—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0333	0.0638	CbGbCtD
Telaprevir—ABCB1—Estramustine—prostate cancer	0.0271	0.052	CbGbCtD
Telaprevir—ALB—Estradiol—prostate cancer	0.0192	0.0368	CbGbCtD
Telaprevir—ABCB1—Cabazitaxel—prostate cancer	0.0179	0.0343	CbGbCtD
Telaprevir—CYP3A4—Bicalutamide—prostate cancer	0.0175	0.0335	CbGbCtD
Telaprevir—ABCB1—Estrone—prostate cancer	0.0175	0.0335	CbGbCtD
Telaprevir—ALB—Prednisone—prostate cancer	0.0165	0.0316	CbGbCtD
Telaprevir—CYP3A4—Estramustine—prostate cancer	0.0162	0.0311	CbGbCtD
Telaprevir—ABCB1—Ethinyl Estradiol—prostate cancer	0.0156	0.0299	CbGbCtD
Telaprevir—CYP3A4—Flutamide—prostate cancer	0.0145	0.0278	CbGbCtD
Telaprevir—CYP3A4—Abiraterone—prostate cancer	0.0145	0.0278	CbGbCtD
Telaprevir—ABCB1—Conjugated Estrogens—prostate cancer	0.0114	0.0219	CbGbCtD
Telaprevir—CYP3A4—Cabazitaxel—prostate cancer	0.0107	0.0205	CbGbCtD
Telaprevir—CYP3A4—Estrone—prostate cancer	0.0105	0.0201	CbGbCtD
Telaprevir—ABCB1—Mitoxantrone—prostate cancer	0.0104	0.0199	CbGbCtD
Telaprevir—ABCB1—Estradiol—prostate cancer	0.01	0.0192	CbGbCtD
Telaprevir—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00933	0.0179	CbGbCtD
Telaprevir—ABCB1—Prednisone—prostate cancer	0.00863	0.0165	CbGbCtD
Telaprevir—CYP3A4—Conjugated Estrogens—prostate cancer	0.00685	0.0131	CbGbCtD
Telaprevir—ABCB1—Etoposide—prostate cancer	0.00655	0.0126	CbGbCtD
Telaprevir—CYP3A4—Mitoxantrone—prostate cancer	0.00622	0.0119	CbGbCtD
Telaprevir—CYP3A4—Estradiol—prostate cancer	0.00601	0.0115	CbGbCtD
Telaprevir—ABCB1—Docetaxel—prostate cancer	0.00599	0.0115	CbGbCtD
Telaprevir—CMA1—prostate gland—prostate cancer	0.00544	0.11	CbGeAlD
Telaprevir—CYP3A4—Prednisone—prostate cancer	0.00517	0.00991	CbGbCtD
Telaprevir—ABCB1—Doxorubicin—prostate cancer	0.00447	0.00857	CbGbCtD
Telaprevir—CYP3A4—Etoposide—prostate cancer	0.00392	0.00753	CbGbCtD
Telaprevir—CYP3A4—Docetaxel—prostate cancer	0.00359	0.00689	CbGbCtD
Telaprevir—CTSK—prostate gland—prostate cancer	0.0035	0.0709	CbGeAlD
Telaprevir—CTSS—prostate gland—prostate cancer	0.00307	0.0621	CbGeAlD
Telaprevir—CTSK—seminal vesicle—prostate cancer	0.00296	0.06	CbGeAlD
Telaprevir—CMA1—bone marrow—prostate cancer	0.0028	0.0567	CbGeAlD
Telaprevir—CYP3A4—Doxorubicin—prostate cancer	0.00268	0.00513	CbGbCtD
Telaprevir—CTSS—seminal vesicle—prostate cancer	0.0026	0.0525	CbGeAlD
Telaprevir—CTSK—renal system—prostate cancer	0.00239	0.0483	CbGeAlD
Telaprevir—CTSK—urethra—prostate cancer	0.00235	0.0475	CbGeAlD
Telaprevir—Boceprevir—CYP3A5—prostate cancer	0.00227	0.698	CrCbGaD
Telaprevir—CYP3A4—urine—prostate cancer	0.00213	0.0431	CbGeAlD
Telaprevir—CTSS—renal system—prostate cancer	0.00209	0.0423	CbGeAlD
Telaprevir—CTSS—urethra—prostate cancer	0.00206	0.0416	CbGeAlD
Telaprevir—ORM1—prostate gland—prostate cancer	0.00183	0.0371	CbGeAlD
Telaprevir—CTSK—bone marrow—prostate cancer	0.00181	0.0365	CbGeAlD
Telaprevir—CMA1—lymph node—prostate cancer	0.00174	0.0351	CbGeAlD
Telaprevir—CTSS—bone marrow—prostate cancer	0.00158	0.032	CbGeAlD
Telaprevir—CTSK—testis—prostate cancer	0.00154	0.0312	CbGeAlD
Telaprevir—CTSS—testis—prostate cancer	0.00135	0.0274	CbGeAlD
Telaprevir—CTSK—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.00128	0.276	CbGdCrCtD
Telaprevir—CTSK—lymph node—prostate cancer	0.00112	0.0226	CbGeAlD
Telaprevir—CTSK—Estradiol—Estramustine—prostate cancer	0.00109	0.235	CbGdCrCtD
Telaprevir—Boceprevir—CYP3A4—prostate cancer	0.000983	0.302	CrCbGaD
Telaprevir—CTSS—lymph node—prostate cancer	0.000981	0.0198	CbGeAlD
Telaprevir—ORM1—bone marrow—prostate cancer	0.000945	0.0191	CbGeAlD
Telaprevir—CTSK—Estradiol—Estrone—prostate cancer	0.000867	0.187	CbGdCrCtD
Telaprevir—CTSK—Estradiol—Conjugated Estrogens—prostate cancer	0.000763	0.164	CbGdCrCtD
Telaprevir—ALB—testis—prostate cancer	0.000708	0.0143	CbGeAlD
Telaprevir—CTSK—Estradiol—Ethinyl Estradiol—prostate cancer	0.000641	0.138	CbGdCrCtD
Telaprevir—ORM1—lymph node—prostate cancer	0.000585	0.0118	CbGeAlD
Telaprevir—ABCB1—prostate gland—prostate cancer	0.000542	0.011	CbGeAlD
Telaprevir—CYP3A4—renal system—prostate cancer	0.000522	0.0106	CbGeAlD
Telaprevir—ALB—lymph node—prostate cancer	0.000513	0.0104	CbGeAlD
Telaprevir—ABCB1—seminal vesicle—prostate cancer	0.000458	0.00927	CbGeAlD
Telaprevir—ABCB1—epithelium—prostate cancer	0.000398	0.00805	CbGeAlD
Telaprevir—ABCB1—renal system—prostate cancer	0.000369	0.00747	CbGeAlD
Telaprevir—ABCB1—urethra—prostate cancer	0.000363	0.00734	CbGeAlD
Telaprevir—ABCB1—bone marrow—prostate cancer	0.000279	0.00565	CbGeAlD
Telaprevir—ABCB1—testis—prostate cancer	0.000239	0.00483	CbGeAlD
Telaprevir—Toxic epidermal necrolysis—Docetaxel—prostate cancer	0.000193	0.00133	CcSEcCtD
Telaprevir—Candida infection—Epirubicin—prostate cancer	0.00019	0.00131	CcSEcCtD
Telaprevir—Hypokalaemia—Capecitabine—prostate cancer	0.000189	0.00131	CcSEcCtD
Telaprevir—Vomiting—Bicalutamide—prostate cancer	0.000189	0.0013	CcSEcCtD
Telaprevir—Hepatobiliary disease—Etoposide—prostate cancer	0.000188	0.0013	CcSEcCtD
Telaprevir—Blood uric acid increased—Doxorubicin—prostate cancer	0.000188	0.0013	CcSEcCtD
Telaprevir—Rash—Bicalutamide—prostate cancer	0.000187	0.00129	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Capecitabine—prostate cancer	0.000187	0.00129	CcSEcCtD
Telaprevir—Dermatitis—Bicalutamide—prostate cancer	0.000187	0.00129	CcSEcCtD
Telaprevir—Dysgeusia—Mitoxantrone—prostate cancer	0.000183	0.00126	CcSEcCtD
Telaprevir—Asthenia—Ethinyl Estradiol—prostate cancer	0.00018	0.00124	CcSEcCtD
Telaprevir—Syncope—Estradiol—prostate cancer	0.00018	0.00124	CcSEcCtD
Telaprevir—Fatigue—Goserelin—prostate cancer	0.000178	0.00123	CcSEcCtD
Telaprevir—Pruritus—Ethinyl Estradiol—prostate cancer	0.000178	0.00123	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000177	0.00122	CcSEcCtD
Telaprevir—Urinary tract disorder—Etoposide—prostate cancer	0.000176	0.00122	CcSEcCtD
Telaprevir—Fatigue—Conjugated Estrogens—prostate cancer	0.000176	0.00122	CcSEcCtD
Telaprevir—Nausea—Bicalutamide—prostate cancer	0.000176	0.00122	CcSEcCtD
Telaprevir—Loss of consciousness—Estradiol—prostate cancer	0.000176	0.00122	CcSEcCtD
Telaprevir—Candida infection—Doxorubicin—prostate cancer	0.000176	0.00122	CcSEcCtD
Telaprevir—Urethral disorder—Etoposide—prostate cancer	0.000175	0.00121	CcSEcCtD
Telaprevir—ABCB1—lymph node—prostate cancer	0.000173	0.0035	CbGeAlD
Telaprevir—Anaemia—Mitoxantrone—prostate cancer	0.000173	0.00119	CcSEcCtD
Telaprevir—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000172	0.00119	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.00017	0.00117	CcSEcCtD
Telaprevir—Erythema multiforme—Etoposide—prostate cancer	0.000169	0.00117	CcSEcCtD
Telaprevir—Hypokalaemia—Prednisone—prostate cancer	0.000168	0.00116	CcSEcCtD
Telaprevir—Eye disorder—Etoposide—prostate cancer	0.000167	0.00115	CcSEcCtD
Telaprevir—Dizziness—Ethinyl Estradiol—prostate cancer	0.000166	0.00115	CcSEcCtD
Telaprevir—Infestation—Docetaxel—prostate cancer	0.000165	0.00114	CcSEcCtD
Telaprevir—Infestation NOS—Docetaxel—prostate cancer	0.000165	0.00114	CcSEcCtD
Telaprevir—Urticaria—Goserelin—prostate cancer	0.000164	0.00113	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000164	0.00113	CcSEcCtD
Telaprevir—Infection—Estradiol—prostate cancer	0.000163	0.00112	CcSEcCtD
Telaprevir—Urticaria—Conjugated Estrogens—prostate cancer	0.000162	0.00112	CcSEcCtD
Telaprevir—Shock—Estradiol—prostate cancer	0.000161	0.00111	CcSEcCtD
Telaprevir—Eczema—Epirubicin—prostate cancer	0.000161	0.00111	CcSEcCtD
Telaprevir—Nervous system disorder—Estradiol—prostate cancer	0.000161	0.00111	CcSEcCtD
Telaprevir—Infestation NOS—Capecitabine—prostate cancer	0.00016	0.00111	CcSEcCtD
Telaprevir—Infestation—Capecitabine—prostate cancer	0.00016	0.00111	CcSEcCtD
Telaprevir—Vomiting—Ethinyl Estradiol—prostate cancer	0.00016	0.0011	CcSEcCtD
Telaprevir—Skin disorder—Estradiol—prostate cancer	0.000159	0.0011	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000159	0.0011	CcSEcCtD
Telaprevir—Rash—Ethinyl Estradiol—prostate cancer	0.000158	0.00109	CcSEcCtD
Telaprevir—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000158	0.00109	CcSEcCtD
Telaprevir—Renal failure acute—Epirubicin—prostate cancer	0.000157	0.00108	CcSEcCtD
Telaprevir—Hepatobiliary disease—Docetaxel—prostate cancer	0.000156	0.00108	CcSEcCtD
Telaprevir—Dysgeusia—Etoposide—prostate cancer	0.000152	0.00105	CcSEcCtD
Telaprevir—Infection—Mitoxantrone—prostate cancer	0.000152	0.00105	CcSEcCtD
Telaprevir—Hepatobiliary disease—Capecitabine—prostate cancer	0.000151	0.00105	CcSEcCtD
Telaprevir—Shock—Mitoxantrone—prostate cancer	0.00015	0.00104	CcSEcCtD
Telaprevir—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000149	0.00103	CcSEcCtD
Telaprevir—Nausea—Ethinyl Estradiol—prostate cancer	0.000149	0.00103	CcSEcCtD
Telaprevir—Eczema—Doxorubicin—prostate cancer	0.000149	0.00103	CcSEcCtD
Telaprevir—Asthenia—Goserelin—prostate cancer	0.000148	0.00102	CcSEcCtD
Telaprevir—Skin disorder—Mitoxantrone—prostate cancer	0.000148	0.00102	CcSEcCtD
Telaprevir—Asthenia—Conjugated Estrogens—prostate cancer	0.000147	0.00101	CcSEcCtD
Telaprevir—Urinary tract disorder—Docetaxel—prostate cancer	0.000147	0.00101	CcSEcCtD
Telaprevir—Oedema peripheral—Docetaxel—prostate cancer	0.000146	0.00101	CcSEcCtD
Telaprevir—Pruritus—Goserelin—prostate cancer	0.000146	0.00101	CcSEcCtD
Telaprevir—Urethral disorder—Docetaxel—prostate cancer	0.000145	0.001	CcSEcCtD
Telaprevir—Renal failure acute—Doxorubicin—prostate cancer	0.000145	0.001	CcSEcCtD
Telaprevir—Pruritus—Conjugated Estrogens—prostate cancer	0.000145	0.000999	CcSEcCtD
Telaprevir—Anaemia—Etoposide—prostate cancer	0.000144	0.000992	CcSEcCtD
Telaprevir—Urinary tract disorder—Capecitabine—prostate cancer	0.000142	0.00098	CcSEcCtD
Telaprevir—Oedema peripheral—Capecitabine—prostate cancer	0.000142	0.000977	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Estradiol—prostate cancer	0.000141	0.000976	CcSEcCtD
Telaprevir—Diarrhoea—Goserelin—prostate cancer	0.000141	0.000976	CcSEcCtD
Telaprevir—Fatigue—Estradiol—prostate cancer	0.000141	0.000974	CcSEcCtD
Telaprevir—Urethral disorder—Capecitabine—prostate cancer	0.000141	0.000973	CcSEcCtD
Telaprevir—Erythema multiforme—Docetaxel—prostate cancer	0.00014	0.000969	CcSEcCtD
Telaprevir—Diarrhoea—Conjugated Estrogens—prostate cancer	0.00014	0.000966	CcSEcCtD
Telaprevir—Eye disorder—Docetaxel—prostate cancer	0.000139	0.000958	CcSEcCtD
Telaprevir—Loss of consciousness—Etoposide—prostate cancer	0.000137	0.000943	CcSEcCtD
Telaprevir—Dizziness—Goserelin—prostate cancer	0.000137	0.000943	CcSEcCtD
Telaprevir—Erythema multiforme—Capecitabine—prostate cancer	0.000136	0.000938	CcSEcCtD
Telaprevir—Blood creatinine increased—Epirubicin—prostate cancer	0.000136	0.000936	CcSEcCtD
Telaprevir—Dizziness—Conjugated Estrogens—prostate cancer	0.000135	0.000934	CcSEcCtD
Telaprevir—Eye disorder—Capecitabine—prostate cancer	0.000134	0.000927	CcSEcCtD
Telaprevir—Hypokalaemia—Epirubicin—prostate cancer	0.000132	0.000909	CcSEcCtD
Telaprevir—Fatigue—Mitoxantrone—prostate cancer	0.000132	0.000908	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000131	0.000908	CcSEcCtD
Telaprevir—Vomiting—Goserelin—prostate cancer	0.000131	0.000907	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.00013	0.0009	CcSEcCtD
Telaprevir—Rash—Goserelin—prostate cancer	0.00013	0.000899	CcSEcCtD
Telaprevir—Dermatitis—Goserelin—prostate cancer	0.00013	0.000898	CcSEcCtD
Telaprevir—Vomiting—Conjugated Estrogens—prostate cancer	0.00013	0.000898	CcSEcCtD
Telaprevir—Urticaria—Estradiol—prostate cancer	0.00013	0.000898	CcSEcCtD
Telaprevir—Malnutrition—Docetaxel—prostate cancer	0.000129	0.000892	CcSEcCtD
Telaprevir—Rash—Conjugated Estrogens—prostate cancer	0.000129	0.00089	CcSEcCtD
Telaprevir—Dermatitis—Conjugated Estrogens—prostate cancer	0.000129	0.00089	CcSEcCtD
Telaprevir—Dysgeusia—Docetaxel—prostate cancer	0.000127	0.000874	CcSEcCtD
Telaprevir—Infection—Etoposide—prostate cancer	0.000126	0.00087	CcSEcCtD
Telaprevir—Blood creatinine increased—Doxorubicin—prostate cancer	0.000125	0.000866	CcSEcCtD
Telaprevir—Malnutrition—Capecitabine—prostate cancer	0.000125	0.000864	CcSEcCtD
Telaprevir—Thrombocytopenia—Etoposide—prostate cancer	0.000124	0.000858	CcSEcCtD
Telaprevir—Eosinophilia—Epirubicin—prostate cancer	0.000124	0.000855	CcSEcCtD
Telaprevir—Skin disorder—Etoposide—prostate cancer	0.000123	0.000851	CcSEcCtD
Telaprevir—Nausea—Goserelin—prostate cancer	0.000123	0.000847	CcSEcCtD
Telaprevir—Dysgeusia—Capecitabine—prostate cancer	0.000122	0.000846	CcSEcCtD
Telaprevir—Hypokalaemia—Doxorubicin—prostate cancer	0.000122	0.000841	CcSEcCtD
Telaprevir—Nausea—Conjugated Estrogens—prostate cancer	0.000121	0.000839	CcSEcCtD
Telaprevir—Urticaria—Mitoxantrone—prostate cancer	0.000121	0.000837	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000121	0.000832	CcSEcCtD
Telaprevir—Eye disorder—Prednisone—prostate cancer	0.00012	0.000826	CcSEcCtD
Telaprevir—Anaemia—Docetaxel—prostate cancer	0.000119	0.000824	CcSEcCtD
Telaprevir—Asthenia—Estradiol—prostate cancer	0.000117	0.000811	CcSEcCtD
Telaprevir—Syncope—Docetaxel—prostate cancer	0.000116	0.0008	CcSEcCtD
Telaprevir—Pruritus—Estradiol—prostate cancer	0.000116	0.0008	CcSEcCtD
Telaprevir—Anaemia—Capecitabine—prostate cancer	0.000116	0.000798	CcSEcCtD
Telaprevir—Eosinophilia—Doxorubicin—prostate cancer	0.000115	0.000791	CcSEcCtD
Telaprevir—Loss of consciousness—Docetaxel—prostate cancer	0.000114	0.000784	CcSEcCtD
Telaprevir—Syncope—Capecitabine—prostate cancer	0.000112	0.000774	CcSEcCtD
Telaprevir—Diarrhoea—Estradiol—prostate cancer	0.000112	0.000773	CcSEcCtD
Telaprevir—Infestation—Epirubicin—prostate cancer	0.000112	0.00077	CcSEcCtD
Telaprevir—Infestation NOS—Epirubicin—prostate cancer	0.000112	0.00077	CcSEcCtD
Telaprevir—Malnutrition—Prednisone—prostate cancer	0.000111	0.000769	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000111	0.000763	CcSEcCtD
Telaprevir—Loss of consciousness—Capecitabine—prostate cancer	0.00011	0.000759	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Etoposide—prostate cancer	0.00011	0.000756	CcSEcCtD
Telaprevir—Asthenia—Mitoxantrone—prostate cancer	0.000109	0.000756	CcSEcCtD
Telaprevir—Fatigue—Etoposide—prostate cancer	0.000109	0.000755	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000109	0.000754	CcSEcCtD
Telaprevir—Dizziness—Estradiol—prostate cancer	0.000108	0.000747	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000106	0.00073	CcSEcCtD
Telaprevir—Hepatobiliary disease—Epirubicin—prostate cancer	0.000105	0.000728	CcSEcCtD
Telaprevir—Infection—Docetaxel—prostate cancer	0.000105	0.000723	CcSEcCtD
Telaprevir—Diarrhoea—Mitoxantrone—prostate cancer	0.000104	0.000721	CcSEcCtD
Telaprevir—Vomiting—Estradiol—prostate cancer	0.000104	0.000719	CcSEcCtD
Telaprevir—Shock—Docetaxel—prostate cancer	0.000104	0.000716	CcSEcCtD
Telaprevir—Nervous system disorder—Docetaxel—prostate cancer	0.000103	0.000714	CcSEcCtD
Telaprevir—Thrombocytopenia—Docetaxel—prostate cancer	0.000103	0.000713	CcSEcCtD
Telaprevir—Rash—Estradiol—prostate cancer	0.000103	0.000713	CcSEcCtD
Telaprevir—Infestation NOS—Doxorubicin—prostate cancer	0.000103	0.000712	CcSEcCtD
Telaprevir—Infestation—Doxorubicin—prostate cancer	0.000103	0.000712	CcSEcCtD
Telaprevir—Dermatitis—Estradiol—prostate cancer	0.000103	0.000712	CcSEcCtD
Telaprevir—Anaemia—Prednisone—prostate cancer	0.000103	0.000711	CcSEcCtD
Telaprevir—Skin disorder—Docetaxel—prostate cancer	0.000102	0.000707	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000102	0.000706	CcSEcCtD
Telaprevir—Infection—Capecitabine—prostate cancer	0.000101	0.0007	CcSEcCtD
Telaprevir—Urticaria—Etoposide—prostate cancer	0.000101	0.000696	CcSEcCtD
Telaprevir—Shock—Capecitabine—prostate cancer	0.0001	0.000693	CcSEcCtD
Telaprevir—Nervous system disorder—Capecitabine—prostate cancer	0.0001	0.000691	CcSEcCtD
Telaprevir—Thrombocytopenia—Capecitabine—prostate cancer	0.0001	0.00069	CcSEcCtD
Telaprevir—Syncope—Prednisone—prostate cancer	9.99e-05	0.00069	CcSEcCtD
Telaprevir—Skin disorder—Capecitabine—prostate cancer	9.92e-05	0.000685	CcSEcCtD
Telaprevir—Urinary tract disorder—Epirubicin—prostate cancer	9.89e-05	0.000683	CcSEcCtD
Telaprevir—Oedema peripheral—Epirubicin—prostate cancer	9.86e-05	0.000681	CcSEcCtD
Telaprevir—Urethral disorder—Epirubicin—prostate cancer	9.81e-05	0.000678	CcSEcCtD
Telaprevir—Loss of consciousness—Prednisone—prostate cancer	9.79e-05	0.000676	CcSEcCtD
Telaprevir—Hepatobiliary disease—Doxorubicin—prostate cancer	9.76e-05	0.000674	CcSEcCtD
Telaprevir—Nausea—Estradiol—prostate cancer	9.72e-05	0.000671	CcSEcCtD
Telaprevir—Vomiting—Mitoxantrone—prostate cancer	9.7e-05	0.00067	CcSEcCtD
Telaprevir—Rash—Mitoxantrone—prostate cancer	9.62e-05	0.000664	CcSEcCtD
Telaprevir—Dermatitis—Mitoxantrone—prostate cancer	9.61e-05	0.000663	CcSEcCtD
Telaprevir—Erythema multiforme—Epirubicin—prostate cancer	9.47e-05	0.000653	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	9.42e-05	0.00065	CcSEcCtD
Telaprevir—Eye disorder—Epirubicin—prostate cancer	9.36e-05	0.000646	CcSEcCtD
Telaprevir—Urinary tract disorder—Doxorubicin—prostate cancer	9.15e-05	0.000632	CcSEcCtD
Telaprevir—Oedema peripheral—Doxorubicin—prostate cancer	9.12e-05	0.00063	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Docetaxel—prostate cancer	9.1e-05	0.000629	CcSEcCtD
Telaprevir—Asthenia—Etoposide—prostate cancer	9.1e-05	0.000629	CcSEcCtD
Telaprevir—Fatigue—Docetaxel—prostate cancer	9.09e-05	0.000628	CcSEcCtD
Telaprevir—Urethral disorder—Doxorubicin—prostate cancer	9.08e-05	0.000627	CcSEcCtD
Telaprevir—Nausea—Mitoxantrone—prostate cancer	9.06e-05	0.000626	CcSEcCtD
Telaprevir—Infection—Prednisone—prostate cancer	9.03e-05	0.000624	CcSEcCtD
Telaprevir—Pruritus—Etoposide—prostate cancer	8.98e-05	0.00062	CcSEcCtD
Telaprevir—Shock—Prednisone—prostate cancer	8.95e-05	0.000618	CcSEcCtD
Telaprevir—Nervous system disorder—Prednisone—prostate cancer	8.92e-05	0.000616	CcSEcCtD
Telaprevir—Skin disorder—Prednisone—prostate cancer	8.83e-05	0.00061	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Capecitabine—prostate cancer	8.81e-05	0.000609	CcSEcCtD
Telaprevir—Fatigue—Capecitabine—prostate cancer	8.8e-05	0.000608	CcSEcCtD
Telaprevir—Erythema multiforme—Doxorubicin—prostate cancer	8.76e-05	0.000605	CcSEcCtD
Telaprevir—Malnutrition—Epirubicin—prostate cancer	8.71e-05	0.000602	CcSEcCtD
Telaprevir—Diarrhoea—Etoposide—prostate cancer	8.68e-05	0.000599	CcSEcCtD
Telaprevir—Eye disorder—Doxorubicin—prostate cancer	8.66e-05	0.000598	CcSEcCtD
Telaprevir—Dysgeusia—Epirubicin—prostate cancer	8.53e-05	0.000589	CcSEcCtD
Telaprevir—Dizziness—Etoposide—prostate cancer	8.39e-05	0.000579	CcSEcCtD
Telaprevir—Urticaria—Capecitabine—prostate cancer	8.11e-05	0.00056	CcSEcCtD
Telaprevir—Vomiting—Etoposide—prostate cancer	8.07e-05	0.000557	CcSEcCtD
Telaprevir—Malnutrition—Doxorubicin—prostate cancer	8.06e-05	0.000557	CcSEcCtD
Telaprevir—Anaemia—Epirubicin—prostate cancer	8.05e-05	0.000556	CcSEcCtD
Telaprevir—Rash—Etoposide—prostate cancer	8e-05	0.000552	CcSEcCtD
Telaprevir—Dermatitis—Etoposide—prostate cancer	7.99e-05	0.000552	CcSEcCtD
Telaprevir—Dysgeusia—Doxorubicin—prostate cancer	7.9e-05	0.000545	CcSEcCtD
Telaprevir—Fatigue—Prednisone—prostate cancer	7.84e-05	0.000541	CcSEcCtD
Telaprevir—Syncope—Epirubicin—prostate cancer	7.81e-05	0.00054	CcSEcCtD
Telaprevir—Loss of consciousness—Epirubicin—prostate cancer	7.66e-05	0.000529	CcSEcCtD
Telaprevir—Asthenia—Docetaxel—prostate cancer	7.57e-05	0.000522	CcSEcCtD
Telaprevir—Nausea—Etoposide—prostate cancer	7.54e-05	0.00052	CcSEcCtD
Telaprevir—Pruritus—Docetaxel—prostate cancer	7.46e-05	0.000515	CcSEcCtD
Telaprevir—Anaemia—Doxorubicin—prostate cancer	7.45e-05	0.000515	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	7.37e-05	0.000509	CcSEcCtD
Telaprevir—Asthenia—Capecitabine—prostate cancer	7.32e-05	0.000506	CcSEcCtD
Telaprevir—Syncope—Doxorubicin—prostate cancer	7.23e-05	0.000499	CcSEcCtD
Telaprevir—Urticaria—Prednisone—prostate cancer	7.22e-05	0.000499	CcSEcCtD
Telaprevir—Pruritus—Capecitabine—prostate cancer	7.22e-05	0.000499	CcSEcCtD
Telaprevir—Diarrhoea—Docetaxel—prostate cancer	7.21e-05	0.000498	CcSEcCtD
Telaprevir—Loss of consciousness—Doxorubicin—prostate cancer	7.09e-05	0.000489	CcSEcCtD
Telaprevir—Infection—Epirubicin—prostate cancer	7.07e-05	0.000488	CcSEcCtD
Telaprevir—Shock—Epirubicin—prostate cancer	7e-05	0.000483	CcSEcCtD
Telaprevir—Diarrhoea—Capecitabine—prostate cancer	6.99e-05	0.000482	CcSEcCtD
Telaprevir—Nervous system disorder—Epirubicin—prostate cancer	6.97e-05	0.000482	CcSEcCtD
Telaprevir—Dizziness—Docetaxel—prostate cancer	6.97e-05	0.000481	CcSEcCtD
Telaprevir—Thrombocytopenia—Epirubicin—prostate cancer	6.96e-05	0.000481	CcSEcCtD
Telaprevir—Skin disorder—Epirubicin—prostate cancer	6.91e-05	0.000477	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.82e-05	0.000471	CcSEcCtD
Telaprevir—Dizziness—Capecitabine—prostate cancer	6.75e-05	0.000466	CcSEcCtD
Telaprevir—Vomiting—Docetaxel—prostate cancer	6.7e-05	0.000463	CcSEcCtD
Telaprevir—Rash—Docetaxel—prostate cancer	6.65e-05	0.000459	CcSEcCtD
Telaprevir—Dermatitis—Docetaxel—prostate cancer	6.64e-05	0.000459	CcSEcCtD
Telaprevir—Infection—Doxorubicin—prostate cancer	6.54e-05	0.000451	CcSEcCtD
Telaprevir—Asthenia—Prednisone—prostate cancer	6.52e-05	0.00045	CcSEcCtD
Telaprevir—Vomiting—Capecitabine—prostate cancer	6.49e-05	0.000448	CcSEcCtD
Telaprevir—Shock—Doxorubicin—prostate cancer	6.47e-05	0.000447	CcSEcCtD
Telaprevir—Nervous system disorder—Doxorubicin—prostate cancer	6.45e-05	0.000446	CcSEcCtD
Telaprevir—Thrombocytopenia—Doxorubicin—prostate cancer	6.44e-05	0.000445	CcSEcCtD
Telaprevir—Rash—Capecitabine—prostate cancer	6.44e-05	0.000444	CcSEcCtD
Telaprevir—Pruritus—Prednisone—prostate cancer	6.43e-05	0.000444	CcSEcCtD
Telaprevir—Dermatitis—Capecitabine—prostate cancer	6.43e-05	0.000444	CcSEcCtD
Telaprevir—Skin disorder—Doxorubicin—prostate cancer	6.39e-05	0.000441	CcSEcCtD
Telaprevir—Nausea—Docetaxel—prostate cancer	6.26e-05	0.000432	CcSEcCtD
Telaprevir—Diarrhoea—Prednisone—prostate cancer	6.22e-05	0.00043	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Epirubicin—prostate cancer	6.14e-05	0.000424	CcSEcCtD
Telaprevir—Fatigue—Epirubicin—prostate cancer	6.13e-05	0.000423	CcSEcCtD
Telaprevir—Nausea—Capecitabine—prostate cancer	6.06e-05	0.000419	CcSEcCtD
Telaprevir—Dizziness—Prednisone—prostate cancer	6.01e-05	0.000415	CcSEcCtD
Telaprevir—Vomiting—Prednisone—prostate cancer	5.78e-05	0.000399	CcSEcCtD
Telaprevir—Rash—Prednisone—prostate cancer	5.73e-05	0.000396	CcSEcCtD
Telaprevir—Dermatitis—Prednisone—prostate cancer	5.73e-05	0.000395	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.68e-05	0.000392	CcSEcCtD
Telaprevir—Fatigue—Doxorubicin—prostate cancer	5.67e-05	0.000392	CcSEcCtD
Telaprevir—Urticaria—Epirubicin—prostate cancer	5.65e-05	0.00039	CcSEcCtD
Telaprevir—Nausea—Prednisone—prostate cancer	5.4e-05	0.000373	CcSEcCtD
Telaprevir—Urticaria—Doxorubicin—prostate cancer	5.23e-05	0.000361	CcSEcCtD
Telaprevir—Asthenia—Epirubicin—prostate cancer	5.1e-05	0.000352	CcSEcCtD
Telaprevir—Pruritus—Epirubicin—prostate cancer	5.03e-05	0.000347	CcSEcCtD
Telaprevir—Diarrhoea—Epirubicin—prostate cancer	4.87e-05	0.000336	CcSEcCtD
Telaprevir—Asthenia—Doxorubicin—prostate cancer	4.72e-05	0.000326	CcSEcCtD
Telaprevir—Dizziness—Epirubicin—prostate cancer	4.7e-05	0.000325	CcSEcCtD
Telaprevir—Pruritus—Doxorubicin—prostate cancer	4.66e-05	0.000321	CcSEcCtD
Telaprevir—Vomiting—Epirubicin—prostate cancer	4.52e-05	0.000312	CcSEcCtD
Telaprevir—Diarrhoea—Doxorubicin—prostate cancer	4.5e-05	0.000311	CcSEcCtD
Telaprevir—Rash—Epirubicin—prostate cancer	4.48e-05	0.00031	CcSEcCtD
Telaprevir—Dermatitis—Epirubicin—prostate cancer	4.48e-05	0.000309	CcSEcCtD
Telaprevir—Dizziness—Doxorubicin—prostate cancer	4.35e-05	0.0003	CcSEcCtD
Telaprevir—Nausea—Epirubicin—prostate cancer	4.22e-05	0.000292	CcSEcCtD
Telaprevir—Vomiting—Doxorubicin—prostate cancer	4.18e-05	0.000289	CcSEcCtD
Telaprevir—Rash—Doxorubicin—prostate cancer	4.15e-05	0.000286	CcSEcCtD
Telaprevir—Dermatitis—Doxorubicin—prostate cancer	4.15e-05	0.000286	CcSEcCtD
Telaprevir—Nausea—Doxorubicin—prostate cancer	3.91e-05	0.00027	CcSEcCtD
Telaprevir—ABCB1—Metabolism—PDHA1—prostate cancer	7.46e-06	5.47e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—UCP3—prostate cancer	7.46e-06	5.47e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTA3—prostate cancer	7.46e-06	5.47e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PLAU—prostate cancer	7.36e-06	5.4e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTA1—prostate cancer	7.32e-06	5.37e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—prostate cancer	7.26e-06	5.33e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTO1—prostate cancer	7.24e-06	5.31e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HSD3B2—prostate cancer	7.24e-06	5.31e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NAT2—prostate cancer	7.24e-06	5.31e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CAV1—prostate cancer	7.18e-06	5.27e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AMACR—prostate cancer	7.13e-06	5.23e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP3A43—prostate cancer	7.13e-06	5.23e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SRD5A2—prostate cancer	7.13e-06	5.23e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NAT1—prostate cancer	7.13e-06	5.23e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—DEGS1—prostate cancer	7.13e-06	5.23e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC22A3—prostate cancer	7.11e-06	5.22e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HSD3B1—prostate cancer	7.11e-06	5.22e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	6.97e-06	5.11e-05	CbGpPWpGaD
Telaprevir—CTSS—Immune System—AKT1—prostate cancer	6.96e-06	5.11e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.96e-06	5.11e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PLCB2—prostate cancer	6.94e-06	5.09e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP2C18—prostate cancer	6.94e-06	5.09e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—LRP2—prostate cancer	6.94e-06	5.09e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	6.88e-06	5.05e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	6.86e-06	5.04e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTA4—prostate cancer	6.82e-06	5e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TBXAS1—prostate cancer	6.82e-06	5e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—P4HB—prostate cancer	6.8e-06	4.99e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HSD17B1—prostate cancer	6.8e-06	4.99e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	6.73e-06	4.94e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6—prostate cancer	6.65e-06	4.88e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTA2—prostate cancer	6.65e-06	4.88e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC22A1—prostate cancer	6.62e-06	4.86e-05	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	6.61e-06	4.86e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SULT1A1—prostate cancer	6.56e-06	4.82e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ABCG5—prostate cancer	6.56e-06	4.82e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CG—prostate cancer	6.54e-06	4.8e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.54e-06	4.8e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—EGF—prostate cancer	6.47e-06	4.75e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SULT2A1—prostate cancer	6.45e-06	4.73e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTA1—prostate cancer	6.41e-06	4.71e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	6.36e-06	4.67e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MED12—prostate cancer	6.34e-06	4.66e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HSD3B2—prostate cancer	6.34e-06	4.65e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTO1—prostate cancer	6.34e-06	4.65e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NAT2—prostate cancer	6.34e-06	4.65e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GNG5—prostate cancer	6.29e-06	4.62e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AKT1—prostate cancer	6.13e-06	4.5e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP2C18—prostate cancer	6.08e-06	4.46e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PLCB2—prostate cancer	6.08e-06	4.46e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—LRP2—prostate cancer	6.08e-06	4.46e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CREBBP—prostate cancer	6.07e-06	4.45e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NCOA3—prostate cancer	6.06e-06	4.45e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HPGD—prostate cancer	6.06e-06	4.45e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—B4GALT4—prostate cancer	6.06e-06	4.45e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IGF1—prostate cancer	5.99e-06	4.4e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—P4HB—prostate cancer	5.96e-06	4.37e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.96e-06	4.37e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	5.93e-06	4.35e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	5.84e-06	4.29e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC22A1—prostate cancer	5.8e-06	4.26e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	5.8e-06	4.25e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HPGDS—prostate cancer	5.78e-06	4.25e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CD—prostate cancer	5.75e-06	4.22e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP2C19—prostate cancer	5.75e-06	4.22e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TNFRSF21—prostate cancer	5.7e-06	4.18e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SERPINE1—prostate cancer	5.69e-06	4.18e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SULT2A1—prostate cancer	5.65e-06	4.15e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	5.65e-06	4.15e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTT1—prostate cancer	5.61e-06	4.12e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ACHE—prostate cancer	5.61e-06	4.12e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MED12—prostate cancer	5.56e-06	4.08e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP2A6—prostate cancer	5.55e-06	4.07e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP7B1—prostate cancer	5.54e-06	4.07e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTAP—prostate cancer	5.54e-06	4.07e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.52e-06	4.05e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GNG5—prostate cancer	5.51e-06	4.05e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS3—prostate cancer	5.43e-06	3.99e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.4e-06	3.96e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.4e-06	3.96e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKR1C3—prostate cancer	5.39e-06	3.96e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PRKACB—prostate cancer	5.37e-06	3.94e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NCOA3—prostate cancer	5.31e-06	3.9e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP17A1—prostate cancer	5.31e-06	3.9e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—JAK2—prostate cancer	5.28e-06	3.88e-05	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.25e-06	3.86e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.24e-06	3.84e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.15e-06	3.78e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ACSL4—prostate cancer	5.15e-06	3.78e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HPGDS—prostate cancer	5.07e-06	3.72e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NCOA2—prostate cancer	5.06e-06	3.71e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP2C19—prostate cancer	5.04e-06	3.7e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CB—prostate cancer	5.01e-06	3.68e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—UMPS—prostate cancer	4.94e-06	3.63e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PHGDH—prostate cancer	4.94e-06	3.63e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ARG2—prostate cancer	4.94e-06	3.63e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTT1—prostate cancer	4.92e-06	3.61e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ACHE—prostate cancer	4.92e-06	3.61e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP2A6—prostate cancer	4.86e-06	3.57e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—LDHB—prostate cancer	4.85e-06	3.56e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	4.84e-06	3.56e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC5A5—prostate cancer	4.83e-06	3.54e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	4.77e-06	3.5e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP3A5—prostate cancer	4.76e-06	3.49e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKR1C3—prostate cancer	4.73e-06	3.47e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP2E1—prostate cancer	4.72e-06	3.46e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PRKACB—prostate cancer	4.7e-06	3.45e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NQO1—prostate cancer	4.66e-06	3.42e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP17A1—prostate cancer	4.65e-06	3.42e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IL2—prostate cancer	4.61e-06	3.38e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.6e-06	3.38e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TH—prostate cancer	4.59e-06	3.37e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTA3—prostate cancer	4.59e-06	3.37e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TCN2—prostate cancer	4.59e-06	3.37e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—UCP3—prostate cancer	4.59e-06	3.37e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PDHA1—prostate cancer	4.59e-06	3.37e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.57e-06	3.35e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP3A4—prostate cancer	4.55e-06	3.34e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.52e-06	3.32e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP1B1—prostate cancer	4.47e-06	3.28e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NCOA2—prostate cancer	4.43e-06	3.25e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.38e-06	3.22e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.38e-06	3.22e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GGT1—prostate cancer	4.33e-06	3.18e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NCOA1—prostate cancer	4.26e-06	3.13e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC5A5—prostate cancer	4.23e-06	3.1e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP19A1—prostate cancer	4.2e-06	3.08e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.2e-06	3.08e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTA4—prostate cancer	4.2e-06	3.08e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—EP300—prostate cancer	4.13e-06	3.03e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP2E1—prostate cancer	4.13e-06	3.03e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTA2—prostate cancer	4.09e-06	3e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NQO1—prostate cancer	4.09e-06	3e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—RXRA—prostate cancer	4.06e-06	2.98e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCG5—prostate cancer	4.04e-06	2.97e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.04e-06	2.97e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TH—prostate cancer	4.03e-06	2.95e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SRC—prostate cancer	4.02e-06	2.95e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP3A4—prostate cancer	3.98e-06	2.92e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTA1—prostate cancer	3.95e-06	2.9e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.94e-06	2.9e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP1B1—prostate cancer	3.92e-06	2.87e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—prostate cancer	3.91e-06	2.87e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—COMT—prostate cancer	3.91e-06	2.87e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NAT2—prostate cancer	3.91e-06	2.87e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTO1—prostate cancer	3.91e-06	2.87e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.91e-06	2.87e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTP1—prostate cancer	3.89e-06	2.85e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ITPR1—prostate cancer	3.83e-06	2.81e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GGT1—prostate cancer	3.79e-06	2.78e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.76e-06	2.76e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PLCB2—prostate cancer	3.74e-06	2.75e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—LRP2—prostate cancer	3.74e-06	2.75e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP2C18—prostate cancer	3.74e-06	2.75e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NCOA1—prostate cancer	3.74e-06	2.74e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP19A1—prostate cancer	3.68e-06	2.7e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—P4HB—prostate cancer	3.67e-06	2.7e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TYMS—prostate cancer	3.62e-06	2.65e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TGFB1—prostate cancer	3.59e-06	2.64e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GSTM1—prostate cancer	3.57e-06	2.62e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.57e-06	2.62e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—RXRA—prostate cancer	3.55e-06	2.61e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—LPL—prostate cancer	3.51e-06	2.57e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.48e-06	2.55e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MED12—prostate cancer	3.42e-06	2.51e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—COMT—prostate cancer	3.42e-06	2.51e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTP1—prostate cancer	3.41e-06	2.5e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GNG5—prostate cancer	3.4e-06	2.49e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP1A1—prostate cancer	3.39e-06	2.49e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ERCC2—prostate cancer	3.36e-06	2.47e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ITPR1—prostate cancer	3.35e-06	2.46e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—prostate cancer	3.33e-06	2.44e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NCOA3—prostate cancer	3.27e-06	2.4e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TYMS—prostate cancer	3.17e-06	2.32e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTHFR—prostate cancer	3.16e-06	2.32e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GSTM1—prostate cancer	3.13e-06	2.3e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HPGDS—prostate cancer	3.12e-06	2.29e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.1e-06	2.28e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPARA—prostate cancer	3.1e-06	2.27e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—LPL—prostate cancer	3.07e-06	2.26e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CA—prostate cancer	3.06e-06	2.24e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ACHE—prostate cancer	3.03e-06	2.22e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTT1—prostate cancer	3.03e-06	2.22e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.99e-06	2.2e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP1A1—prostate cancer	2.97e-06	2.18e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—prostate cancer	2.96e-06	2.17e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ERCC2—prostate cancer	2.94e-06	2.16e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CAV1—prostate cancer	2.91e-06	2.14e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.91e-06	2.14e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PRKACB—prostate cancer	2.9e-06	2.13e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.87e-06	2.1e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.78e-06	2.04e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTHFR—prostate cancer	2.77e-06	2.03e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NCOA2—prostate cancer	2.73e-06	2e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPARA—prostate cancer	2.71e-06	1.99e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CG—prostate cancer	2.65e-06	1.95e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.61e-06	1.91e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CAV1—prostate cancer	2.55e-06	1.87e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.55e-06	1.87e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NQO1—prostate cancer	2.52e-06	1.85e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—INS—prostate cancer	2.51e-06	1.84e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT1—prostate cancer	2.5e-06	1.83e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TH—prostate cancer	2.48e-06	1.82e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CREBBP—prostate cancer	2.46e-06	1.81e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.41e-06	1.77e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GGT1—prostate cancer	2.34e-06	1.72e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CD—prostate cancer	2.33e-06	1.71e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CG—prostate cancer	2.32e-06	1.71e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NCOA1—prostate cancer	2.3e-06	1.69e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.27e-06	1.67e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NOS3—prostate cancer	2.2e-06	1.62e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—INS—prostate cancer	2.2e-06	1.62e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—RXRA—prostate cancer	2.19e-06	1.61e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CREBBP—prostate cancer	2.16e-06	1.58e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—COMT—prostate cancer	2.11e-06	1.55e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTP1—prostate cancer	2.1e-06	1.54e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ITPR1—prostate cancer	2.07e-06	1.52e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CD—prostate cancer	2.04e-06	1.5e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CB—prostate cancer	2.03e-06	1.49e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—prostate cancer	2.01e-06	1.48e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TYMS—prostate cancer	1.95e-06	1.43e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NOS3—prostate cancer	1.93e-06	1.42e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GSTM1—prostate cancer	1.93e-06	1.42e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—LPL—prostate cancer	1.89e-06	1.39e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.83e-06	1.34e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ERCC2—prostate cancer	1.81e-06	1.33e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CB—prostate cancer	1.78e-06	1.31e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—prostate cancer	1.77e-06	1.3e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTEN—prostate cancer	1.76e-06	1.29e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTHFR—prostate cancer	1.7e-06	1.25e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—EP300—prostate cancer	1.68e-06	1.23e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPARA—prostate cancer	1.67e-06	1.23e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CAV1—prostate cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTEN—prostate cancer	1.54e-06	1.13e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—EP300—prostate cancer	1.47e-06	1.08e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.43e-06	1.05e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—INS—prostate cancer	1.36e-06	9.95e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CREBBP—prostate cancer	1.33e-06	9.75e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.26e-06	9.24e-06	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CA—prostate cancer	1.24e-06	9.1e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NOS3—prostate cancer	1.19e-06	8.73e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.1e-06	8.06e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—prostate cancer	1.09e-06	7.98e-06	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CA—prostate cancer	1.09e-06	7.97e-06	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKT1—prostate cancer	1.01e-06	7.43e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTEN—prostate cancer	9.48e-07	6.96e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—EP300—prostate cancer	9.04e-07	6.64e-06	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKT1—prostate cancer	8.87e-07	6.51e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.69e-07	4.91e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKT1—prostate cancer	5.47e-07	4.01e-06	CbGpPWpGaD
